change from semaglutide to tirzepatide For the first time, and were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at maximum tolerated dose. The Switching from Tirzepatide to Semaglutide

MITHOCONDRIAL FUNCTION Mitochondria generate the energy that powers your lifefrom intense workouts to creative thinking

10.1093/eurpub/ckaa165.1408 84

Research Director National Institute of Integrative Medicine Copyright 2005-2026 Linus Pauling Institute Figure Alternative Text Figure 1

But those taking a GLP-1 for weight loss may think about reducing their dose or even stopping completely once they reach their goal weight

Weight Loss Mechanisms That Work Independently of Appetite Beyond appetite suppression, GLP-1 therapy triggers fat cell biology changes that drive weight loss without requiring additional calorie restriction